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Psd1 is a defensin, isolated from Pisum sativum seeds, previously shown to have a strong 
interaction with fungal-specific membrane components. Candida albicans is an important human 
pathogen, causing oral, genital and systemic opportunistic infections, which are especially relevant 
clinically in immunocompromised patients, such as HIV-infected individuals. 
We tested the effects of this antimicrobial peptide against three C. albicans strains, of which one 
was a mutant that lacked the capability to produce glucosylceramide. We compared Psd1 with the 
antifungal drugs amphotericin B and fluconazole, at the minimal inhibitory concentration (MIC) and at a 
10-fold higher concentration. Using atomic force microscopy (AFM) imaging and force spectroscopy, we 
assessed morphological changes and alterations in membrane stiffness on C. albicans planktonic cells. To 
determine whether Psd1 has an apoptosis triggering effect in the pathogen, a flow cytometry analysis was 
performed on Psd1 treated cells, after staining with propidium iodide and annexin V conjugated to FITC. 
Our results show that, with increasing incubation times and Psd1 concentrations, there is an 
increased surface roughness with the appearance of membrane features, such as blebs, cell size alterations, 
loss of volume and leakage of cellular contents. Also, Psd1 causes a loss of stiffness in the cell membrane 
and increases the percentage of apoptotic cells. In a general way, Psd1 has less antifungal action against 
the mutant strain, leading to assign glucosylceramide as one of its molecular targets in C. albicans. We 
were able to study the action of Psd1 against a relevant fungal human pathogen, aiming at its possible use 
as a natural antimycotic agent. 
 





As defensinas são um dos maiores grupos de péptidos antimicrobianos (AMPs) e têm sido alvo de 
investigação intensiva nos últimos anos. Os AMPs são péptidos encontrados no sistema imunitário de 
eucariotas, que têm uma larga atividade antibacteriana, antifúngica, antiviral e também anticancerígena. 
Estes péptidos são uma possível alternativa aos antibióticos utilizados hoje em dia, que com o decorrer 
dos anos têm perdido eficácia e cujos microrganismos contra os quais são utilizados têm desenvolvido 
cada vez mais mecanismos de resistência. A Psd1 é uma defensina com propriedades antifúngicas isolada 
de sementes de Pisum sativum. Tem 46 resíduos de aminoácidos e uma estrutura secundária composta por 
uma hélice α e folhas β, estabilizada por quatro pontes persulfureto. Foi recentemente demonstrado que 
este péptido tem grande afinidade, com elevada especificidade, para membranas modelo enriquecidas em 
ergosterol, o principal esterol presente nas membranas de fungos, e glucosilceramida, o glicoesfingolípido 
mais comum em fungos. Contrariamente, não existe interação entre o péptido e membranas modelo 
enriquecidas em colesterol, que simulam células de mamífero, levando a uma toxicidade reduzida para 
células humanas. 
A ação antifúngica da Psd1 foi anteriormente testada contra diferentes fungos, tendo sido 
descoberto em estudos com Neurospora crassa que tem afinidade para uma proteína relacionada com o 
controlo do ciclo celular, a ciclina F. Ao se ligar à ciclina F, a Psd1 provoca uma paragem no ciclo celular, 
promovendo endorreduplicação e perturbando a migração nuclear. Foi também testada por outros autores 
a sua ação contra duas estirpes de Candida albicans, uma estirpe nativa (WT) e uma estirpe derivada da 
WT e mutante na glucosilceramida sintetase, tendo-se demonstrado que a Psd1 causa uma menor inibição 
no crescimento da estirpe mutante. Estes resultados demonstram que a ação antifúngica da Psd1 envolve 
uma elevada afinidade para componentes na membrana em C. albicans, como as glucosilceramidas. 
Candida albicans é um importante agente patogénico que causa infeções oportunistas orais, 
genitais e sistémicas em humanos, sendo especialmente relevante em pacientes imunocomprometidos, tais 
como indivíduos infetados com o vírus HIV. Este fungo normalmente existe como comensal na 
microflora gastrointestinal e nas mucosas bucal ou vaginal. Mais de 50% da população humana pode ser 
portadora de C. albicans como comensal sem ter qualquer efeito negativo. Contudo, este fungo pode 
alternar o seu estado de comensal para invasivo, dependendo de alguns fatores relacionados com o 
hospedeiro, tais como perturbação da microflora normal de algumas mucosas, imunossupressão ou 
disrupção de funções protetoras de barreiras como a pele. C. albicans possui vários fatores de virulência 
que possibilitam a sua patogenicidade. Estes incluem dimorfismo morfológico, expressão de adesinas e 
invasinas à superfície celular, tigmotropismo, formação de biofilmes, switching fenotípico, secreção de 
enzimas hidrolíticas e atributos relacionados com aptidão biológica, como resposta ao stress mediada por 
proteínas de choque térmico (HSPs) ou excreção de amónia para alcalinizar o ambiente extracelular. 
Em organismos unicelulares, a apoptose é um processo de morte celular programada que pode ser 
encarado como um processo em que a morte altruísta de algumas células pode ser benéfica para a 
população como um todo ao promover a sua sobrevivência. A apoptose é regulada por uma complexa 
x 
rede de proteínas (caspases) e de processos metabólicos. Em fungos existe pelo menos um ortólogo das 
caspases de mamíferos: a metacaspase YCA1 (yeast caspase 1). Alguns efeitos que definem este processo 
incluem alterações proteómicas nas mitocôndrias, libertação de citocromo c no citosol, aumento de 
produção de espécies reativas de oxigénio, aparecimento de marcadores apoptóticos, tais como vesículas 
membranares, ou perda de volume celular. Testes de rotina para a deteção de caraterísticas apoptóticas 
são utilizados para a identificação de células que estejam a passar por um processo apoptótico após 
tratamento com agentes antifúngicos. Esta prática é comum quando se estudam os efeitos de péptidos 
antimicrobianos em C. albicans. 
Neste trabalho, testámos os efeitos da Psd1 em três estirpes de C. albicans, um isolado clínico e as 
duas estirpes referidas anteriormente, a WT e a mutante na glucosilceramida sintetase, para determinar se 
a ausência deste glicoesfingolípido interfere na ação da defensina, sob o ponto de vista biofísico e das 
características estudadas nesta tese. Comparámos a Psd1 com as drogas antifúngicas anfotericina B e 
fluconazol, um polieno e um azol, respetivamente. A anfotericina B é um composto que se liga 
irreversivelmente ao ergosterol presente na membrana celular de fungos, formando poros que levam à 
perda de conteúdos intracelulares e, posteriormente, à morte celular. O fluconazol necessita entrar dentro 
da célula para surtir o seu efeito, que consiste na perturbação da síntese de ergosterol, ao impedir que o 
seu percursor, lanosterol, seja desmetilado. Para as três estirpes de C. albicans foi determinada a 
concentração mínima inibitória (MIC) destes compostos com atividade antifúngica, que foram 
posteriormente testados à concentração correspondente à MIC e a uma concentração 10 vezes superior. 
Utilizando imagens de microscopia de força atómica (AFM) e espetroscopia de força baseada em AFM, 
avaliámos alterações na morfologia, tais como rugosidade da superfície da célula e perda de volume 
celular, e alterações biomecânicas de células plantónicas de C. albicans, ao nível da rigidez membranar. 
Para determinar se a Psd1 tem a capacidade de provocar apoptose neste agente patogénico, foi efetuada 
uma análise de citometria de fluxo em células tratadas com Psd1, após marcação com as sondas 
fluorescentes iodeto de propídeo e anexina conjugada a FITC. 
Os nossos resultados demonstram que, com o aumento de concentração e o tempo de incubação 
com Psd1, há um aumento da rugosidade da membrana celular, verificado pela visualização e pela análise 
de imagens de altura obtidas por AFM. Através de imagens de AFM obtidas em modo de erro, verificou-
se também o aparecimento de caraterísticas associadas à apoptose, tais como vesículas membranares, 
alterações de tamanho e perdas de volume e de conteúdos celulares. Pôde-se também visualizar que as 
células parecem ter uma menor capacidade de adesão após tratamento com o péptido, o que pode indicar 
que a Psd1 tem a capacidade de interferir com a formação de biofilmes, visto que esta caraterística é 
determinante para a formação destes consórcios microbianos. Considerando as alterações morfológicas 
causadas pela defensina, o modelo que melhor explica o mecanismo de interação do péptido com a 
membrana é o modelo de carpete, com um efeito de detergente e micelização da membrana, em que há 
uma perturbação da organização e homogeneização membranar, sem a formação de poros na membrana. 
Pelos dados obtidos por espetroscopia de força baseada em AFM, foi calculado o módulo de Young, 
verificando-se uma diminuição da rigidez celular após tratamento com a defensina ou com qualquer dos 
xi 
outros compostos antifúngicos, o que também foi visualizado em imagens de AFM em modo de contraste 
de fase. Foi também possível determinar que a rigidez média das células de C. albicans mutante é 
intrinsecamente menor que a de células de C. albicans WT, o que está de acordo com o facto de as 
membranas ricas em ceramidas serem mais rígidas. Através de dados de citometria de fluxo, foi registado 
um aumento na percentagem de células apoptóticas. 
De um modo geral, a Psd1 tem menor ação antifúngica contra a estirpe mutante, indicando que a 
glucosilceramida possa ser um dos seus alvos moleculares em C. albicans. Foi assim possível adquirir um 
conhecimento mais alargado da ação da Psd1 contra um agente patogénico humano importante, 
apontando para o seu possível uso como um agente antimicótico de origem natural. 
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1. Candida albicans 
Candida albicans is an important human pathogen, causing oral, genital and systemic opportunistic 
infections, which are especially relevant clinically in immunocompromised patients, such as HIV-infected 
individuals, making this one of the most important pathogenic fungi (Berman, 2012). C. albicans 
normally exists as a commensal as part of mucosal microflora, such as the oral cavity, the gastrointestinal 
tract or the vagina (Ruhnke and Maschmeyer, 2002; Calderone and Clancy, 2012). More than 50% of the 
human population may carry C. albicans as a commensal without having any negative effect. However, 
this fungi can switch from commensal to invasive state, depending on some host factors, such as the 
disruption of normal mucosal flora, impaired barrier protective functions and immunosuppression (Mayer 
et al., 2012). Despite the existence of currently available antifungal therapies, mortality and morbidity 
caused by this pathogen are still inadmissibly high (Behnsen et al., 2008).  
 
1.1. Candida albicans pathogenicity 
C. albicans possesses a number of major virulence factors (Figure 1), which enable its 
pathogenicity. These include morphological dimorphism, which consists in the transition between yeast 
and hyphal forms (Figure 1 B) (Berman and Sudbery, 2002; Zheng and Wang, 2004); the expression of 
adhesins and invasins on the cell surface, which permit the adherence to host cell surfaces (Figure 1 A) 
(Verstrepen and Klis, 2006; Wachtler et al., 2011) and induce endocytosis uptake of the fungus (Phan et 
al., 2005; Zhu and Filler, 2009), respectively; thigmotropism, i.e., directed growth stimulated by contact 
with host cells (Figure 1 C) (Brand et al., 2007; Kumamoto, 2008); biofilm formation possible due to the 
attachment of planktonic yeast cells to abiotic, e.g., catheters, or biotic surfaces, e.g., host cells, with yeast 
cells in the lower part and hyphal cells in the upper part of the biofilm (Figure 1 E) (Nobile et al., 2009; 
Finkel and Mitchell, 2010); a second form of phenotypic switching (plasticity) between white and opaque 
forms, which exhibit marked differences in their ability to undergo filamentation; and the secretion of 
hydrolytic enzymes (Figure 1 D) (Mayer et al., 2012; Poulain, 2012; Si et al., 2013).  
In addition to these virulence factors, fitness attributes include stress response mediated by heat 
shock proteins (Hsps) (Lindquist, 1992), auto-induction of hyphal formation through amino acid uptake 
(Vylkova et al., 2011), excretion of ammonia (NH3) and subsequent extracellular alkalinization, uptake of 
different compounds as carbon and nitrogen sources (Brock, 2009; Fleck et al., 2011) and essential metals 
like iron, zinc, copper and manganese (Figure 1 F) (Heymann et al., 2002; Marvin et al., 2003; Citiulo et 




Figure 1. Overview of the major pathogenicity mechanisms of Candida albicans. Image adapted from Mayer et 
al., 2012. 
 
1.2. Fungal targets for antifungal drugs 
Fungi possess a unique cell wall and cell membrane that can serve as targets for antifungal agents. 
The fungal cell membrane is similar to that of other eukaryotic cells, composed of a lipid bilayer with 
proteins embedded within it (Katzung et al., 2011). Sterols are major components of fungal membranes 
and this component is absent in all prokaryotes. The sterol present in higher eukaryotic membranes is 
cholesterol, but in fungal membranes the main sterol present is ergosterol, which provides stability and 
flexibility to the cell membrane (Thevissen et al., 1999; Thevissen et al., 2003). 
Polyenes, such as amphotericin B target the cell membrane. Amphotericin B is a lipophylic 
molecule that crosses the cell wall and aggregates closely and irreversibly with ergosterol, forming a pore 
in the membrane (Figure 2), resulting in loss of intracellular contents and, ultimately, in total impairment 
of cell membrane function, leading to cell death (Carrillo-Munõz et al., 2006). The azoles, such as 
fluconazole or itraconazole, are a family of drugs that also target the cell membrane, although indirectly, 
because they need to enter the cell to exert their function (Figure 2). Lanosterol serves as a precursor for 
ergosterol and although many enzymes are a part of this reaction, 14-α demethylase is responsible for the 
demethylation of lanosterol and is an essential enzyme that serves as a target for azole antifungal agents. 
14-α demethylase requires cytochrome P450 mediation to exert its function; the azoles bind to this 
cytochrome inhibiting the demethylation of lanosterol and, thus, the synthesis of ergosterol (Ghannoum 
and Rice, 1999). The lack of ergosterol in the fungal cell membrane makes it very unstable, eventually 




Figure 2. Fungal cell wall and cell membrane representation. Targets for polyenes and azoles are shown here, 
polyenes form pores in the membrane and azoles inhibit the formation of ergosterol. Image adapted from Katzung et 
al., 2011. 
 
Glycosphingolipids (GSL) are a family of lipids that act as key components of biological 
membranes. They exist in animals, plants and fungi (Leipelt et al., 2001; Halter et al., 2007; Daniotti and 
Iglesias-Bartolome, 2011). GSL were initially described as components of the architecture of cell 
membranes, straightly connected with fluidity and stability (Feinstein et al., 1975; Aaronson and Martin, 
1983; Campanella, 1992). Recently, however, it was demonstrated that their role goes clearly beyond the 
initial concept, since these molecules are major components of specialized membrane domains called 
lipid rafts (Bagnat et al., 2001; Hakomori, 2003; Hakomori, 2008). GSL have been characterized as 
important structures in cell-cell interaction, cell signaling and protein sorting (Bagnat et al., 2000; Bagnat 
and Simons, 2002; Nimrichter et al., 2008; Staubach and Hanisch, 2011). Lipid rafts are more ordered and 
tightly packed than the surrounding bilayer and serve as organizing centers for the assembly of signaling 
molecules, influencing membrane fluidity and membrane proteins trafficking (Chiantia and London, 
2013). 
The most common GSL found in fungi is glucosylceramide (GlcCer) (Figure 2), present in the 
membranes of most fungi, such as Pichia pastoris, C. albicans, Cryptococcus neoformans, Aspergillus 
fumigatus, Sporothrix schenckii and Neurospora crassa (Saito et al., 2006). Large amounts of this 
glycosphingolipid have also been found in the fungal cell wall (Nimrichter and Rodrigues, 2011). GlcCer 
has been identified as a fungal component decades ago. Its functions during fungal growth/dimorphism, 
lipid raft formation and correlation with virulence have been reported (Rittershaus et al., 2006). In fact, it 
was recently shown to be required for virulence in C. albicans (de Medeiros et al., 2010; Noble et al., 
2010; de Coninck et al., 2013). 
Work published by Karin Thevissen and coworkers strongly suggested that targeting fungal GlcCer 
with the AMPs RsAFP2 and HsAFP1 could initiate a cell signaling response in fungal organisms, with 
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formation of reactive oxygen species (ROS) and subsequent cell death by apoptosis (Thevissen et al., 
2004; Aerts et al., 2007; Aerts et al., 2009; Aerts et al., 2011). The use of anti-GlcCer antibodies was 
shown to block germ tube formation in C. albicans, Colletotrichum gloeosporioides and Pseudallescheria 
boydii (Pinto et al., 2002; da Silva et al., 2004), and also to protect mice in lethal infection of C. 
neoformans (Rodrigues et al., 2007).  
The crescent knowledge of GlcCer functions in eukaryotes (may these be related to virulence, 
growth or morphological transitions), together with the findings described above, can be connected to 
specific and essential structural features and particular biosynthetic steps to validate these GSL as 
potential targets on the development and discovery of new antifungal drugs (Nimrichter and Rodrigues, 
2011; Gonçalves et al., 2012b). 
 
1.3. Apoptosis in yeast 
Apoptotic cell death seemed like a process that was absent in yeast, until the unexpected discovery 
of an apoptotic phenotype in a yeast, over a decade ago (Madeo et al., 1997). Until then, the development 
and conservation of a programmed cell death (PCD) did not make sense for a unicellular organism, since 
that would mean the death of the organism. So the fact that yeast apoptosis follows the same 
physiological purpose known for multicellular organisms, namely eliminating superfluous cells, 
demanded a conceptual change. 
Yeast populations should not be interpreted just as a group of partitioned unicellular organisms that 
do not communicate among each other, but rather as a multicellular community of interacting individuals. 
Under certain circumstances, the death of a single cell might be beneficial for the whole population, thus 
promoting the survival of the clone. Several physiological scenarios in which altruistic death of single 
cells promotes survival of the population as a whole support this idea (Buttner et al., 2006). For example, 
death of older cells helps to preserve vanishing resources, stimulating the survival of younger and fitter 
cells (Vachova and Palkova, 2005). Apoptosis may also occur to clear the population of non-recombinant 
cells after meiosis, infertile cells or damaged haploid cells (guaranteeing the adaptive benefit of the 
diploid state) (Severin and Hyman, 2002). Several stimuli can trigger apoptotic pathways. Internal 
triggers may be aging and mutations such as DNA damage and replication failure (Weinberger et al., 
2005). 
Apoptosis is regulated by a complex network of proteins and metabolic pathways. The central core 
of this process is regulated by a family of proteins named caspases. Yeasts have at least one ortholog of 
mammalian caspases: the metacaspase YCA1 (yeast caspase 1) (Madeo et al., 2002).  
Apoptosis may be defined as a process that causes proteomic alterations in mitochondria, release of 
cytochrome c to the cytosol, DNA fragmentation, phosphatidylserine (PS) externalization, chromatin 
condensation, increased ROS production, and development of apoptotic markers such as membrane blebs 
or cell shrinkage (Figure 3) (Carmona-Gutierrez et al., 2010; Cho et al., 2012). Routinely used assays 
aiming at the detection of these apoptotic features are used for the identification of fungal cells 
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undergoing apoptosis after treatment with antifungal agents. This practice is common when studying the 




Figure 3. Apoptotic pathways in yeast cells. Image from Cho et al., 2012. 
 
C. albicans is clinically relevant and, lately, research on antimicrobial peptides using this fungal 
pathogen as target has been increasing. RsAFP2 (Terras et al., 1992; Aerts et al., 2007; Aerts et al., 2009; 
Thevissen et al., 2012), HsAFP1 (Osborn et al., 1995; Aerts et al., 2011), human β-defensins 1-3 
(Schroder and Harder, 1999; Sahl et al., 2005), coprisin (Hwang et al., 2009; Lee et al., 2012), juruin (Fry 
et al., 2009; Ayroza et al., 2012) and crotamine (Gonçalves and Polson, 1947; Nicastro et al., 2003; Fadel 
et al., 2005; Yamane et al., 2013) are just a few examples of research on possible alternatives to the most 
commonly used antifungal therapies.  
 
2. Antimicrobial Peptides 
Naturally occurring AMPs probably represent one of the first evolved and successful forms of 
chemical defense of eukaryotic cells against bacteria, protozoa, fungi and viruses (Ganz and Lehrer, 1998; 
Lehrer and Ganz, 1999; Zasloff, 2002; Mookherjee and Hancock, 2007; Lai and Gallo, 2009; Guo et al., 
2012), being also active against cancer cells (Hoskin and Ramamoorthy, 2008; Gaspar et al., 2013). 
Currently commercialized antibiotics are mostly of microbial origin or synthesized from those. These 
antibiotics are losing efficacy as a result of high selection pressure and rapid emergence of resistance in 
many important human pathogens, threatening to put an end to the golden age of antibiotics (Clardy et al., 
2009). The use of antifungal treatments has increased as a consequence of the increase of 
immunocompromised patients, mostly due to improvements in oncology and transplant fields (Mehra et 
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al., 2012), leading to more frequent resistances to the drugs used. An alternative to this problem can be 
found in the innate immune system of plants (Thomma et al., 2002; Lay and Anderson, 2005; Gonçalves 
et al., 2012b), fungi (Mygind et al., 2005; Schneider et al., 2010; Oeemig et al., 2012), invertebrates 
(Bulet and Stocklin, 2005; Ayroza et al., 2012) and vertebrates (Ganz, 2004; Sahl et al., 2005; van Dijk et 
al., 2008; Gonçalves et al., 2012a), where AMPs are found, presenting a broad spectrum of antimicrobial 
activities. 
AMPs have variable amino acid composition and size (ranging from less than 10 to more than 100 
amino acid residues), commonly being cationic and amphipathic molecules. To date, nearly 2300 AMPs 
have been identified (either natural or synthetic), as listed by the Antimicrobial Peptide Database (APD; 
http://aps.unmc.edu/AP/main.php), of which over 1800 have antibacterial activity and more than 800 
have antifungal activity. This discrepancy, however, may be redundant and antibacterial AMPs may also 
have antifungal activity that has not yet been investigated. 
According to structural classification, AMPs are divided into four families: β-strand, such as 
protegrin (Aumelas et al., 1996); α-helix, such as dermaseptin (Mor et al., 1991); αβ-motif, such as 
drosomicin (Landon et al., 1997); and non-αβ or extended, such as indolicidin (Ladokhin et al., 1999). 
Although some AMPs have had their target unveiled, many mechanisms of antifungal action still remain 
unclear. AMPs may target membranes, and induce their effect by disrupting them (Shai, 1999), or they 
may enter the cell and exert their action intracellularly (Hancock and Rozek, 2002; Oberparleiter et al., 
2003). 
 
3. Models of membrane activity – mechanism of action of AMPs 
Besides GlcCer, fungal membranes are also rich in phosphomannans and in the negatively charged 
phospholipids phosphatidylinositol (PI), PS and diphosphatidylglycerol (DPG), which confer high 
negative charge surface to the membranes (Pasupuleti et al., 2011).  
The biological activity of AMPs is strongly influenced by peptide-membrane interaction. To 
explain differential membrane affinity, biological activities and modes of action of some AMPs as a 
function of their concentration, interaction of defensins with models of fungal membranes have been 
reported, showing a strong dependence on lipid composition (de Medeiros et al., 2010; Gonçalves et al., 
2012a; Gonçalves et al., 2012b). As with other AMPs, the mechanism of action of some plant defensins 
with antifungal activity involves membrane binding, leading to its permeabilization, binding to the cell 
wall, interaction with intracellular targets which would lead to apoptosis, membrane permeabilization and 
receptor-mediated internalization (van der Weerden et al., 2013). 
The mode of action of some defensins has been studied by using synthetic lipid vesicles mimicking 
the lipid composition of fungal, bacterial and mammal membranes (de Medeiros et al., 2010; Wimley and 
Hristova, 2011; Gonçalves et al., 2012a; Gonçalves et al., 2012b). The permeabilization models used to 
explain the mode of action of defensins could be classified into two main groups: transmembrane pore 
formation, such as the barrel-stave and toroidal models, and non-pore formation, such as the carpet, 
aggregate channel, Shai-Matsuzaki-Huang, lipid clustering and interfacial activity models (Alba et al., 
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2012). The carpet model can evolve to disrupt the membrane through pore formation models or through a 
detergent-like mechanism, with micellization of the membrane (Bechinger and Lohner, 2006; Chang et al., 
2008; Hoskin and Ramamoorthy, 2008). There are currently at least three different commonly accepted 
models describing possible AMPs mode of action: the barrel-stave pore model, the toroidal pore model, 
and the carpet model (Shai, 2002; Chang et al., 2008; Hoskin and Ramamoorthy, 2008; Alba et al., 2012). 
Most defensins are amphipathic molecules with clusters of positively charged amino acid residues 
side chains and hydrophobic amino acid side chains (Lehrer and Lu, 2011). This structural behavior 
allows them to interact with microbial membranes both at the level of the negatively charged 
phospholipids head groups and of the hydrophobic fatty acid chains. The orientation of the peptide on the 
membrane surface depends on the specific peptide-lipid system, but it is common for the AMP to stay at 
the membrane interface until a threshold peptide concentration is reached (Yang et al., 2000; Yount and 
Yeaman, 2005; Pasupuleti et al., 2011). 
 
 
Figure 4. Models of lipid membrane 
permeabilization by AMPs. Initially, the 
peptide (magenta) is adsorbed at the membrane 
surface. After an initial recognition of the 
surface, a conformation change of the peptide 
occurs. Image from Silva et al., 2013 (submitted, 





In the barrel stave model (Figure 4), once the critical threshold concentration of peptide is reached, 
peptides self-aggregate in the membrane resulting in the formation of a transmembrane pore lined by 
peptide, which dissipates proton and ionic gradients (Ehrenstein and Lecar, 1977; Reddy et al., 2004), but 
the membrane thickness and homogeneity do not change (Chang et al., 2008). The toroidal pore model is 
a variant of the barrel stave model, claiming that, at some critical peptide concentration, curvature strain 
induces membranes to curve inward, resulting in the formation of a pore that is lined by both peptides and 
lipid headgroups (Figure 4). Toroidal pores seem to have varying lifetimes and longer-lived pores may 
have a lethal effect similar to barrel-stave pores, with dissipation of protonic and ionic gradients. This 
type of mechanism of AMPs action also causes a decrease in membrane thickness and a slightly 
decreased surface homogeneity (Chang et al., 2008). In the carpet model (Figure 4), peptides bind to 
phospholipid head groups by electrostatic interactions and align themselves parallel to the membrane 
surface in a carpet-like fashion until a critical threshold concentration is reached. When a detergent-like 
membrane micellization takes place, a strong decrease of membrane homogeneity occurs (Chang et al., 
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2008; Hoskin and Ramamoorthy, 2008; Epand et al., 2010; Hazlett and Wu, 2011; Pasupuleti et al., 2011; 
Li et al., 2012). 
 
4. Resistance  
Like antibiotics resistance, it is easily conceivable that AMPs resistance is a key characteristic for 
increased virulence of pathogenic strains. Despite this fact, and contrary to antibiotics that act through a 
single approach (meaning that microbes can evade them through a single resistance system), AMPs 
follow a multidimensional strategy against microbial invasion (Lai and Gallo, 2009) (issue further 
developed in the text, in section 5.1 - Immunomodulatory function). Therefore, selective pressures on 
microbes are avoided, reducing the development of resistant strains (Zasloff, 2002). 
A synergistic effect between different AMPs in the host is also possible, as evidenced by the fact 
that the MIC of AMPs in vitro are usually higher than the physiological concentrations of those AMPs in 
vivo (Lai and Gallo, 2009). Another example is that two distinct AMPs may have their combined MIC 
much lower than when acting isolated, strongly suggesting heterologous host defense peptide interactions 
(Westerhoff et al., 1995). 
AMPs frequently have the ability to disrupt microbial membranes and to inhibit their synthesis; 
thus, strategies to escape the action of those AMPs follow the redesign of cell membranes and have been 
described for both Gram-negative and Gram-positive bacteria (Gunn et al., 2000; Li et al., 2007). Other 
evasion mechanism includes affecting the correct function of the AMP by turning off its expression, 
releasing plasmid DNA in epithelial cells, a strategy adopted by highly contagious bacteria from the 
Shigella genus that cause dysentery (Islam et al., 2001). Since AMPs frequently rely on transmembrane 
potential to interact with and exert their mechanism of action against microbial pathogens, it is probable 
that another strategy for evading AMPs could be to alter their transmembrane energy status (Yeaman and 
Yount, 2003). C. albicans resistance to some AMPs is regulated by the protein Ssd1 (Gank et al., 2008), 
combined with the transcription factor Bcr1 (Jung et al., 2013). This combination gives resistance to the 
α-helical cationic polypeptide protamine, frequently used to screen for antimicrobial peptide susceptibility 
(Yeaman et al., 1996), the synthetic antimicrobial peptide RP-1, modeled upon the C-terminal α-helical 
domain existent in the human platelet factor-4 kinocidins, domain which is responsible for its 
microbicidal activity,  (Bourbigot et al., 2009) and human β-defensin-2, by maintaining mitochondrial 
energetics and reducing membrane permeabilization, thus allowing the fungus to counteract the negative 
effects of these AMPs (Jung et al., 2013). The Hog1 (high osmolarity glycerol) MAPK pathway, which 
provides a response to osmotic, oxidative and heavy-metal exposure stresses in fungal cells, was shown to 
be activated in the presence of antimicrobial peptides (Yeaman et al., 1996; Vylkova et al., 2007; 
Argimon et al., 2011). This MAPK triggers a transcriptional response upon exposure to histatin-5, a 
salivary cationic AMP that has a role in keeping C. albicans in its commensal state, and human β-
defensins 2 and 3. 
Another strategy for evading AMP function is to enzymatically degrade them before they take 
action, by producing proteases and peptidases involved in tissue degradation, as described for C. albicans 
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secreted aspartic proteases (Saps). Namely, histatin-5 is a host-specific substrate of Sap9, enabling the 
transition of the fungus from commensal to pathogenic in HIV
+
 individuals, who have lower levels of this 
isoenzyme in the saliva, causing an increased incidence of oral candidiasis (Meiller et al., 2009; Khan et 
al., 2013). Also regarding histatin-5, a transport mechanism of efflux mediated by the flu-1 transporter 
has been described for C. albicans, rendering the pathogen the ability to reduce the isoenzyme cytosolic 
concentration and fungicidal activity (Li et al., 2013). The LL-37 cathelicidin and histatins bind to cell 
wall carbohydrates, preventing adhesion of C. albicans to host cells; thus, the release of AMP-binding 
proteins acts as a decoy for these AMPs, diverting them from binding to fungal cell surface (den Hertog et 
al., 2005; den Hertog et al., 2006; Mochon and Liu, 2008). Msb2 is a C. albicans surface protein, highly 
soluble and proteolytically stable, which is shed to the extracellular environment, acting as a basal AMP-
resistance strategy by avoiding killing by LL-37 and histatin-5 (Szafranski-Schneider et al., 2012). 
The above characteristics decrease microbes’ susceptibility to AMPs and indicate that microbial 
pathogens have developed some structure-specific and energy-dependent mechanisms to subvert the 
action of host defenses. 
 
5. Defensins 
Defensins comprise one of the largest groups of AMPs. These peptides are cysteine-rich and have 
diverse sequences and structures, stabilized into compact shapes by three or four conserved cysteine 
disulphide bridges, have at least two positive charges (lysine or arginine residues) and are small, ranging 
approximately from 12 to 50 amino acid residues (2-6 kDa) (Ganz, 2003; Ren et al., 2011; Gao and Zhu, 
2012). 
Vertebrate’s defensins are divided in three subfamilies: α-, β- and θ-defensins. α-defensins are 
present in mammals such as humans, monkeys and several rodent species (Ouellette and Selsted, 1996; 
Ganz and Lehrer, 1998; Lehrer and Ganz, 1999). β-defensins are found in a wide range of vertebrates, 
presenting a cysteine-stabilized αβ-motif composed of an antiparallel β-sheet and an α-helix. θ-defensins, 
present only in Old World monkeys, are cyclic and derived from α-defensins (Lehrer, 2004; Lehrer and 
Lu, 2011; Semple and Dorin, 2012). In Figure 5, some conserved amino acids between defensins from 
different kingdoms are shown. 
     
Figure 5. Amino acid residues sequence examples of defensins with antifungal activity. Animal, plant and fungi 
origin: human defensin 5 (HD5), Pisum sativum defensin 1 (Psd1) and Penicillium brevicompactum Dierckx bubble 
protein (BP), respectively. Colored bars underline the conserved cysteines among defensins from different kingdoms. 
Image from Silva et al., 2013 (submitted, under editorial revision). 
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Plants, fungi and many invertebrates produce defensin-like peptides structurally similar to the β-
defensins from vertebrates (Thomma et al., 2002; Bulet and Stocklin, 2005; Mygind et al., 2005; Sahl et 
al., 2005; van Dijk et al., 2008; Ayroza et al., 2012; Oeemig et al., 2012). These observations enabled to 
assume that all defensins and defensin-like peptides evolved from a common precursor (Zhu and Gao, 
2013). The relatively recent identification of three defensins in lower eukaryotes, plectasin from 
Pseudoplectania nigrella (Mygind et al., 2005), eurocin from Eurotium amstelodami (Oeemig et al., 2012) 
and bubble protein from Penicillium brevicompactum Dierckx (Seibold et al., 2011), is important to 
demonstrate the wide distribution of defensins over diverse eukaryotic lineages, which suggests that 
ancestral defensin genes existed over 1500 million years ago, before Fungi, Plantæ and Animalia 
kingdoms diverged (Wang et al., 1999). It is quite likely that these antimicrobial weapons have been 
fundamental to the evolution of multicellular organisms within the microbial environment. 
Although defensins were initially identified as antimicrobial peptides, recent studies have 
demonstrated that they have a much broader range of action, including immunomodulatory function (Ulm 
et al., 2012). 
 
5.1. Immunomodulatory function 
Defensins may be produced constitutively or have their expression triggered when there is an 
inflammatory process by the recognition of microbial conserved structures, such as lipopolysaccharide 
(LPS) and lipoteichoic acid, or inflammatory effectors, like cytokines. These AMPs are expressed 
differentially depending on the peptide itself and on the tissue or cell type (Ulm et al., 2012). 
Defensins, besides their AMP action, are also immunomodulatory molecules and inhibitors of 
virulence factors. Thus, they can enhance the host’s immune system, with this multifunctional character 
rendering these peptides a lower probability of becoming tolerated by microorganisms (Mehra et al., 2012) 
Pro-inflammatory mediation has been recognized in some of these molecules, as they can bind to 
chemokine receptors, being able to recruit immune cells, thus enhancing the immune response 
(Mookherjee and Hancock, 2007; Lai and Gallo, 2009; Alba et al., 2012; Semple and Dorin, 2012; Ulm et 
al., 2012; Zhu and Gao, 2013). Surprisingly, some defensins are also able to attenuate pro-inflammatory 
responses whenever these can be harmful for the organism (Lande et al., 2007; Yamasaki et al., 2007). 
These antagonistic effects depend on the level of expression, disease state and pathogen exposure. It has 
been demonstrated that human β-defensin 3 (mainly expressed in epithelial cells), when in basal 
concentration, has an immunosuppressive effect in the presence of LPS, contributing to the maintenance 
of a non-inflammatory environment over continual low-level exposure to microorganisms, commensal or 
pathogenic (Semple et al., 2010). Due to this multifunctionality, AMPs have also been referred to as host 






5.2. Pisum sativum defensin 1 
Many fungi are phytopathogenic, with species such as Fusarium spp., Cladosporium spp., Pythium 
spp., Curvularia spp., Aspergillus flavus and Puccinia pittieriana affecting potato, rice, corn, wheat, 
tobacco and cotton crops by causing wilt, mold, crown rot, mildew and rust, just to name a few plant 
diseases (The American Phytopathological Society, APS - https://www.apsnet.org/). These diseases can 
deplete entire crops, bearing enormous costs for agriculture due to the difficulty in eliminating fungal 
infections from plants, once they appear. Soils harbor plants for most of their life cycle, but also a 
considerable amount of bacteria, fungi and parasites, many of which can be phytopathogenic. Plants need 
to have good defenses against these microorganisms, thus it is easy conceivable to consider plants as 
major AMPs producers. In fact, much research has been made to screen for these molecules in plants. 
 
 
Figure 6. Representation of the secondary structure 
elements of Psd1 mean structure. The β-strands are 
represented by blue arrows and the α-helix by a red ribbon. 
The four disulphide bridges are shown in stick representation. 




Pisum sativum defensin 1 (Psd1) was firstly characterized in 2000 (Almeida et al., 2000). A 
fraction with antifungal activity against Aspergillus niger was isolated from seeds of the garden pea 
(Pisum sativum) by ammonium sulfate fractionation followed by gel filtration on Sephadex G-75. Further 
purification was performed by reverse-phase high performance liquid chromatography (RP-HPLC). Full 
details of purification process and molecular characterization of Psd1 are found in Almeida et al., 2000. 
At present, the peptide used is recombinant, having the same folding and antifungal activity when 
compared to native Psd1 (Cabral et al., 2003). 
This peptide has 46 amino acid residues and its secondary structure comprises a globular fold 
composed of β-sheets and an α-helix stabilized by four disulphide bridges, i.e., cysteine-stabilized αβ-
motif (Figure 6) (Almeida et al., 2002). Its three-dimensional structure was determined by nuclear 
magnetic resonance (NMR) and is identical to the backbone structure of other defensins and neurotoxins 
(Kobayashi et al., 1991; Cornet et al., 1995). Through surface topology studies, it was suggested by 
Almeida et al., 2002, that Psd1 might have a sodium channel inhibiting activity, due to presenting several 
common features with potassium channel inhibitors. The peptide has also been shown to cause a growth 
inhibition of 100% on C. albicans WT, when using a concentration of 20 μM, against a growth inhibition 
of 70% on a C. albicans strain mutant in the GlcCer synthase gene (de Medeiros, 2009). These results 
point out to the hypothesis that GlcCer may be a possible target for Psd1. 
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As demonstrated by a yeast two-hybrid screening system, Psd1 has affinity to a Neurospora crassa 
protein related to the cell cycle control, cyclin F (Lobo et al., 2007). Using a developing retinal tissue of 
neonatal rats as a model to study this interaction, it was proven that Psd1 impairs the correct cell cycle 
progression, by blocking cyclin F role in the transition of S to G2 phases of the cell cycle, promoting 
endoreduplication and disturbing nuclear migration.  
Recently, it has been demonstrated through partition studies that Psd1 has a high affinity, with high 
specificity, to model membranes enriched in ergosterol, the main sterol present in fungal membranes, and 
GlcCer (Gonçalves et al., 2012b). On the contrary, there is no interaction between the defensin and model 
membranes enriched in cholesterol, which simulate mammalian cells, leading to a reduced Psd1 toxicity 
to human cells. 
 
 
Aims and Goals 
Despite what is already known about Psd1, further insight on its mode of action and effect in C. 
albicans are yet to be known. The aim of this thesis, which is integrated in the work already under 
development at the host laboratory (IMM Biomembranes Unit), was to study the effects of Psd1 on the 
human pathogen C. albicans, using an AFM-based biophysical approach to determine alterations in 
external appearance and biomechanical properties of the cell after treatment with Psd1. In order to 
determine if the defensin induces apoptosis, flow cytometry was also used. Given the recent evidence that 
Psd1 interacts with GlcCer (Gonçalves et al., 2012b), a fungal strain mutant in GlcCer synthase was used, 






The basic theoretical aspects of the main techniques employed in this study are introduced in this 
chapter, followed by a description of experimental procedures and materials used. 
 
1. Atomic Force Microscopy 
Atomic Force microscopy (AFM) first instrument, from 1986, was built by Binnig, Quate and 
Gerber (Binnig et al., 1986) and it is currently in the Science Museum in London, UK. This microscope is 
the successor of the scanning tunnelling microscope (STM), invented in 1981 by Binnig and Rohrer 
(Binnig and Rohrer, 1982). The technique behind how these microscopes work is nothing like the normal 
imaging microscopes that form images by capturing light or electrons from surfaces. The AFM and STM 
are based in a surface profiler invented in the 1920s, the stylus profiler or profilometer, which had a sharp 
tip on the edge of a small cantilever and this tip was dragged through a surface placed upon a moving 
stage. The tip's vertical movement was due to a spring on the opposite end of the cantilever, fixed to a 
stage. The vertical movement of the tip was monitored through the recording of a light signal reflected 
through a mirror in the back of the tip to a photographic film. 
 
 
Figure 7. Atomic force microscopy. A) Schematic representation of the AFM mechanism; B) Height image of C. 
albicans cells made with AFM; C) Approach (red) and retraction (blue) force-distance curves obtained over a C. 
albicans cell. 
 
AFM works very similarly to the stylus profiler, despite their different topographic scales. There is 
a tip in the end of a cantilever and this cantilever is attached to a probe, represented in Figure 7 A. The tip 
scans across a surface, in contact mode or intermittent contact mode. The latter prevents drift of higher 
and or/softer samples. The movements made by this tip, however, are much more controlled by the user 
than the movements of the original cantilever of the stylus profiler, which relied only on a spring at the 
end of the cantilever. The AFM probe is supported on a mechanism of piezoelectric transducers (PZTs), 
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which consist of crystals that change size when an electric charge is applied to them, thus controlling the 
X, Y and Z movements of the probe over the surface. X movements are often called fast and Y 
movements slow (Figure 7 B - axis legends). Some AFMs have the PZTs in the sample holder and not in 
the probe holder.  
The final pseudo-tridimensional images are the result of a convolution of the probe with the surface 
and this information is acquired through the photodetection of a laser pointing at a mirror in the back of 
the cantilever end that holds the sharp tip. Any movement made by the tip in consequence of "feeling" a 
topographic feature, called deflection, alters the position of the laser in the photo detector, which channels 
this information to feedback electronics, the proportional-integral-derivative controllers (PID controllers), 
that allow AFM to keep a constant force and distance to the sample, this is called the feedback loop. The 
photo detector is connected to electronic signal transducers that convert the signal into the output 
information, i.e., digital data that is later analyzed by the user, e.g. images (Figure 7 B) or force-distance 
curves (Figure 7 C). 
There are AFM probes with cantilevers and tips of various shapes, sizes, frequency resonances, 
spring constants, coatings, materials, among other very characteristic features. The combination of these 
characteristics is a very important step of the design of an experiment, because the user needs to have in 
consideration the type of sample, i.e., for soft samples, soft cantilevers should be used, with low 
resonance frequencies and low spring constants; when imaging in contact mode, softer cantilevers have to 
be used because in this mode the tip is always in touch with the sample and the cantilever, being softer, 
adapts easier to changes in sample’s topography. On the contrary, intermittent contact appropriate 
cantilevers have to be longer and stiffer, with higher resonance frequencies, so they can endure being in 
constant vibration over the sample without causing excessive vibration amplitude.  
The amount of information contained in one AFM image is enormous and the user can know the 
height of a chosen point of the image, the contrast phase which allows to see the distribution of harder 
and softer areas in an apparently homogeneous surface, the lateral and vertical deflections suffered by the 
cantilever due to the contact with the surface, among others. Through height images it is possible to know 
the roughness of a certain surface. It is quantified by the vertical deviations of a real surface from its ideal 
form. If these deviations are large, the surface is rough; if they are small the surface is smooth. To know 
this, small crops are performed over the cells surface, these crops are plane fitted to remove any 
concavities or convexities existent in the membrane that are due to the cells shape, resulting in a flat 
image of the membrane crop with only the small features that make the membrane more or less rough. 
Afterwards, the root mean square value of the height irregularities is computed from data variance and 
roughness is calculated as follows:  
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where   represents the equally spaced, ordered points along the trace of the roughness profile, and    is 
the vertical distance from the mean line to the  th point (DeGarmo et al., 2003). 
As far as what concerns AFM-based force spectroscopy, the principle used is the same as for 
images, but in this case, instead of scanning an area of the sample to form images, the tip is placed over a 
specific area where there may be a preliminary recognition of sample topography through force maps 
(similar to height images but with much less resolution and with a different acquiring process) followed 
by the selection of the desired points of the sample where the user wants to perform the force-distance 
curve acquisition. 
Force-distance curves consist of two parts (Figure 7 C), the approach curve, which represents the 
deflection of the cantilever when approaching the sample, and the retraction curve, which represents the 
opposite movement. Depending on the objective of the study, it may be taken in consideration only one 
part of the force-distance curve, e.g. forces of interaction between molecules are measured with retraction 
curves (Carvalho et al., 2013; Franquelim et al., 2013) and forces necessary to perform a given 
nanoindentation on cells are measured with approach curves (Eaton et al., 2012). Nanoindentation is a 
technique used to measure the hardness of small volumes of material, invented in the mid-1970s 
(Ternovskii et al., 1974; Bulychev et al., 1975). To perform nanoindentation to C. albicans in the present 
work, silicon nitride tips with a quadratic pyramid shape were used, as shown in Figure 8. 
 
 
Figure 8. Four-sided pyramid silicon nitride tip 
representation. Half angle to face is the value α to use in 
formula (2). Image adapted from JPK Application Report on 
determining the elastic modulus of biological samples using 
atomic force microscopy. 
 
 
The Young's modulus, or elastic modulus, is a measure of an elastic material’s stiffness, meaning 
that a stiff material has a high Young's modulus and a soft material has a low Young's modulus. 
Assuming that the indenter used is indeformable and that there are no interactions between indenter and 
sample, the Young's Modulus of the sample can be calculated using the Hertzian model. This model 
considers the shallow contact of two spherical bodies; thus, some modifications to the model had to be 
made for each different shape of indenter used (Lin et al., 2007). The following formula is used when the 
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where   is the Young's modulus,   is the force applied to the sample,   is the Poisson's ratio and the 
parameter that describes the sample (for biological samples this parameter is usually set to 0.5) and   is 
the indentation performed in the sample. The Hertz model assumes that the indentation is neglectable 
comparing to sample thickness. Therefore, it is only valid for small indentations around 5 to 10% of cells 
height. 
AFM is a powerful tool of nowadays state of the art research in the several different areas of 
science, like biochemistry, medicine, nanotechnology, physics, material sciences, among others, allowing 
scientist to come up with a biophysical approach (Santos and Castanho, 2004). For some examples of 
AFM applications, consult the following references: protein folding and functionality, such as fibrinogen-
erythrocyte interactions (Carvalho et al., 2010; Carvalho et al., 2011; Carvalho and Santos, 2012; 
Carvalho et al., 2013) or dengue virus capsid protein and low-density lipoproteins interaction (Faustino et 
al., 2013); elasticity and stiffness of cells (Kuznetsova et al., 2007), for example leukemia cells 
(Rosenbluth et al., 2006; Lam et al., 2007) or malaria infected hepatocytes (Eaton et al., 2012); surface 
perturbation of microbial cells after treatment with antimicrobial peptides or other antimicrobial agents 
(Alves et al., 2010; Kim et al., 2011); HIV biophysical studies, like the immature HIV-1 entry regulation 
by virion stiffness (Pang et al., 2013) or  membrane interactions of HIV-1 fusion inhibitors (Franquelim et 
al., 2013); study of tribological properties (tribology is a branch of mechanical engineering and materials 
science that studies the principles of friction, lubrication and wear of interacting surfaces in relative 
motion (Norris et al., 2008)) of chemically and mechanically stable materials with relevance in electronic 
and biomedical applications (Pujari et al., 2013); and thickness control of graphene films with aerospace 
applications (Kuzhir et al., 2013).  
 
2. Flow Cytometry 
Flow cytometers are impedance-based devices that use the Coulter principle, discovered in 1940 by 
Wallace H. Coulter (Graham, 2003; Simson, 2013). The Coulter principle states that particles produce a 
change in impedance when pulled through an orifice, concomitantly with an electric current. This change 
in impedance is proportional to the volume of the particle crossing the orifice and originates from the 
displacement of electrolytes caused by the particle (Simson, 2013). Flow cytometry devices are composed 
of several parts, as shown in Figure 9. 
At the interrogation point (Figure 9 b), it is important that only one particle at the time crosses the 
laser beam, allowing for more accurate data collection. This is accomplished due to the injection of the 
sample solution in a flowing stream of sheath fluid (Figure 9 a), which is then compressed into a very 
narrow passage for the cells to pass (hydrodynamic focusing). Cells with a size range of less than a 
micrometer to several dozens of micrometers can be analyzed by flow cytometry, as long as the user 
makes sure to set the machine with the proper settings, such as speed of sample flow, and also that the 
sample is as clean of debris as possible. In cases when the sample is somewhat contaminated with debris, 
it is possible to use a threshold or cut-off value to exclude those particles from the analysis and assure that 
the majority of events that are collected by the cytometer correspond to the cells of interest. 
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Figure 9. Flow cytometry instrumentation overview. a) the fluidics system, which presents samples to b) the 
interrogation point and takes away the waste, c) the lasers, which are the light source for scatter and fluorescence, d) 
the optics filters and detectors, which gather and detect the light resultant from the intersection of the sample and the 
lasers in the interrogation point, and e) the peripheral electronics and computer system, which converts the signals 
into digital data. Image adapted from probes.invitrogen.com/resources/education. 
 
When cells are hit by the laser, there is a scatter of light in all directions. Light that is scattered in 
the forward direction is called the forward scatter (FSC) and the magnitude of this signal is proportional 
to the size of the cell that is struck by the laser. Light that is scattered to the sides of the cell is called side 
scatter (SSC) and the magnitude of this signal is proportional to the granularity and structural complexity 
inside the cell. Signals collected by FSC and SSC detectors are translated into a voltage pulse and this 
information can be represented in one or two-dimensional plots (Figure 10).  
 
 
Figure 10. One and two-dimensional representations of 
flow cytometry data. When considered alone, one-
dimensional histograms may not be informative of the 
complexity of the populations present in a sample, so the 
user may think there is only one population, when in fact 
there are multiple populations, which can only be 
distinguished by looking at the data in a second dimension. 
This can be done using two-dimensional dot or scatter-








The next level of discrimination of cells is through the emitted fluorescence after excitation by the 
laser. This fluorescence is emitted by fluorescent dyes, which are molecules that have the capacity to emit 
fluorescence after being excited. These dyes can bind to the cells' surface or they may enter the cell and 
find their target intracellularly. 
Each dye has specific excitation and emission wavelengths and spectral profile bandwidth. 
According to this, the laser and detectors set used differs and the choice of which set to use is made in the 
flow cytometry software interface. Sometimes, due to experimental constraints, dyes with close emission 
spectra have to be used and, consequently, there will be fluorescence bleed-through or spectral overlap 
into each of the filters used. This means that some of the fluorescence emitted by the dye A may be 
captured by the detector of the dye B, resulting in an erroneous measure of the intensity of the 
fluorescence of the dye B. It is possible to surpass this problem by adding a few controls to the 
experiment, the single stains. With this, using a process called compensation, the user can excite a sample 
stained with the dye A and collect the fluorescence emitted by it with the detector of the dye B, thus 
knowing the amount of bleed-through of the dye A into the dye B filter, making it possible to remove this 
bleed-through and to collect discrete fluorescence data. 
Similarly to FSC and SSC, fluorescence data collected by the detectors is also translated into 
voltage pulses and this information can be represented in one or two-dimensional plots (Figure 11). When 
using multiple dyes, a three-dimensional plot can also be used. It is possible nowadays to a few 
laboratories in the world to collect up to 18 colors simultaneously. Such requirement of a large number of 
dyes is mostly used in immunology studies. 
 
Figure 11. Flow cytometry two-dimensional dot plot of green 
versus red fluorescence. Q stands for quadrant and each quadrant 
represents a different population: in Q1 and Q3 are dots corresponding 
to cells that exhibit red and green fluorescence, respectively; in Q2 are 
dots corresponding to cells that exhibit both colors (double positives); 
Q4 is the quadrant where the double negatives locate. Not always the 
separation among populations is as clear as in this example. Image 
adapted from: probes.invitrogen.com/resources/education. 
 
 
Flow cytometry is a unique tool that provides the possibility to gather statistic data of a large 
number of cells and use that information to correlate multiple parameters within a cell population. These 
characteristics make it an important tool in a number of fields, such as microbiology, pathology, 
immunology, molecular biology, plant biology and others (Rodrigues et al., 2007; Caiado et al., 2013; 




Materials and Methods 
Unless mentioned otherwise, all reagents were of analytical grade and were purchase from Sigma-
Aldrich (St. Louis, MO, USA). 
 
1. Cell Suspension 
The strains used were a C. albicans clinical isolate (CI) from a patient of Hospital de Santa Maria 
(Lisbon, Portugal), C. albicans SC5314 (WT) and C. albicans SC5314 CAI4 (Δgcs). In Δgcs strain the 
GlcCer synthase gene was disrupted (molecular genetics details of mutant and WT counterpart in Leipelt 
et al., 2001). Strains stocks were kept at -80ºC, with 15% glycerol. 10 μl of the cells in stock, previously 
thawed, were inoculated onto Yeast Peptone Dextrose (YPD) agar and incubated for 48 h at 37ºC. After 
this period, an isolated fungal colony was suspended in YPD broth and allowed to grow overnight at 25ºC, 
with 180 rpm agitation. The cells were then centrifuged at 1882 g for 10 min and washed three times 
under the same conditions using 10 mM HEPES buffer, pH 7.4, with 150mM NaCl. Afterwards, cells 
were counted on hemocytometer to determine cell concentration and the initial suspension was then 
diluted to the concentration necessary for each experiment. 
 
2. Antifungal susceptibility – minimal inhibitory concentration determination 
In vitro antifungal susceptibility tests were performed to determine the minimal inhibitory 
concentrations. RPMI 1640 medium (Gibco-Life Technologies, UK) was used, supplemented with L-
glutamine and 2% glucose, buffered to pH 7.4, with 0.165 M MOPS (3-morpholinopropanesulfonic acid) 
(AppliChem, Gmbh, Germany). The antifungal drugs tested were Amph B FCZ, which were diluted in 
RPMI 1640 medium and final drugs concentration ranged from 0.001 to 62.5 µg/ml, over 17 wells, in a 
volume of 100 μl per each well. Afterwards, 80 µl of RPMI1640 and 20 µl of 10
4
 cell/ml were added. 
Final volume in each well was 200 μl and final cell concentration was 10
3
 cell/ml. The MIC was 
determined by the microdilution method, performed in a 96-well polystyrene flat-bottom plate (TPP, 
Trasadingen, Switzerland) following the guidelines of the Clinical Laboratory Standard Institute (CLSI, 
Wayne, PA, USA). Wells with RPMI1640 and cell inoculum were included as positive control and wells 
with RPMI1640 without inoculum were included as negative control. 200 µl of deionized sterile water 
were placed in all of periphery wells to minimize evaporation inside the plate. Plates were incubated for 
48 h, at 37ºC, after which optical density was read at 540 nm. MIC was defined as the minimal 
concentration of a drug that, after incubation, causes 100% growth inhibition of an organism (Andrews, 
2001). Experiments were performed in triplicate and values were analyzed with GraphPad Prism 5, using 
the Gompertz equation for MIC determination (Lambert and Pearson, 2000). Due to sample restrictions, 
MIC values for Psd1 were not determined. However, at a concentration of 20 µM (or 90.0 µg/ml) of Psd1, 
it has been previously described a growth inhibition of 100% and 70% for both C. albicans WT and 
mutant strains, respectively (de Medeiros, 2009).  
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3. Atomic Force Microscopy (AFM) 
AFM studies were conducted using a JPK NanoWizard II (Berlin, Germany) mounted on a Zeiss 
Axiovert 200 inverted microscope (Jena, Germany). 
 
3.1. Imaging 
C. albicans washed suspensions were incubated at 25ºC in HEPES buffer, with agitation, with 
Amph B, FCZ or Psd1, for 6 and 24 h. Antifungic final concentrations were equal to the MIC and 10-fold 
higher than the MIC. Cell final concentration was set to 10
5
 cell/ml and control samples were incubated 
without any treatment. Cells used in this procedure were resuspended with HEPES buffer, after having 
been washed. A 100 µL droplet of each test sample was applied onto a poly-L-lysine (PLL)-coated glass 
slide and left at 25°C for 2 h. After deposition, the samples were rinsed 10 times with deionized sterile 
water and air-dried at 25°C. 
Measurements were carried out in intermittent contact mode, at room temperature, using uncoated 
silicon ACL cantilevers (Applied NanoStructure, Santa Clara, CA, USA). These cantilevers have typical 
resonance frequencies of 145-230 kHz and spring constants of 20-90 N/m. The scan rate was set to less 
than 1 Hz for imaging and image resolution was set to 512 pixel
2
 for all images. Height, error signal 
(often called amplitude) and phase contrast images were recorded, and line-fitted as required. Height and 
size information was acquired with the JPK Data Processing software 4.2.27. 
Roughness analysis of AFM height images was performed using the Gwyddion 2.31 software (free 
software). Roughness was calculated from the root mean square value (RMS, i.e., standard deviation of 
distribution of heights over 1 m
2
 crop image). The results of this processing were statistically analyzed 
using analysis of variances (ANOVA) and Bonferroni post-tests. 
 
3.2. Force Spectroscopy  
C. albicans washed suspensions were incubated at room temperature, with agitation, with Amph B, 
FCZ or Psd1, for 24 h. Antifungic final concentrations were 10-fold higher than the MIC. Cell final 
concentration was set to 10
6
 cell/ml and control samples were incubated without any treatment. 100 µL of 
sample were placed onto a PLL-coated glass slide and left at 25°C for 2 h. After deposition, the samples 
were rinsed 3 times with HEPES buffer to remove any cells that had not adhered to the PLL-coated glass 
slide. 100 µL of HEPES buffer were added to the adhered cells to avoid sample drying. Measurements 
were carried out in HEPES buffer at 25º C, using the 200 µm long gold reflex coated silicon-nitride 
OMCL-TR400PSA-1 cantilevers (Olympus, Tokio, Japan). These cantilevers have typical resonance 
frequencies of 8-14 kHz and spring constants of approximately 0.02 N/m. 
First, to have a prior overview of the cells shape and height, force maps were performed using a 10 
µm/s approach and retraction speed, Z length of 3 µm and a relative set-point of 0.4 V. The coordinates 
on the map were then chosen (Figure SF1 in the Appendix - Supplementary data section). Afterwards, 
one location per each cell was chosen and force-distance measurements were conducted over those 
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coordinates, in triplicate, using a 3 µm/s approach and retraction speed, Z length of 3 µm and a relative 
set-point of 0.4 V. These conditions of height and applied force ensure that the indentation ranged is 5 to 
10% of cells height, mandatory requirement for measuring cell stiffness. Retraction force-distance curves 
were processed with the JPK Data Processing software 4.2.27. After processing, the four-sided pyramid 
Hertz modified equation was applied to the curves and the Young's modulus obtained. The results of this 
processing were statistically analyzed using analysis of variances (ANOVA) and Bonferroni post-tests. 
 
4. Flow Cytometry 
To determine if Psd1 triggers apoptosis in C. albicans, a flow cytometry analysis was performed 
using annexin V conjugated to fluorescein isothiocyanate (annexin V-FITC) and propidium iodide (PI) 
(Invitrogen, Carlsbad, CA, USA). Annexin V is a human anticoagulant, with high affinity to PS. Annexin 
V is coupled with FITC, which emits green fluorescence, making it possible to identify apoptotic cells by 
binding to PS in the outer leaflet (Koopman et al., 1994). Live cells and apoptotic cells are impermeable 
to PI, but dead cells are stained with red fluorescence through the dye binding to nucleic acids in the cell. 
After the staining process with annexin V and PI, apoptotic cells show green fluorescence, dead cells 
show red fluorescence and dead cells that went through an apoptotic process before dying show red and 
green fluorescence; these are called necrotic cells (Fink and Cookson, 2005). 
C. albicans washed suspensions were incubated at 25ºC, with agitation, with Amph B, FCZ or 
Psd1, for 24 h. Antifungic final concentrations were equal to the MIC. Cell concentration was set to 10
7
 
cell/ml and control samples were incubated without any treatment. After the incubation, cells were 
harvested and washed with cold PBS. After centrifuging and discarding the supernatant, cells were 
resuspended with annexin-binding buffer (Invitrogen, Carlsbad, CA, USA) and final cell concentration 
was set to 10
6
 cell/ml. Afterwards, annexin V-FITC in a 5:100 proportion and PI in a 1 µg/ml final 
concentration were added to the samples. Incubation took place at room temperature for 15 min. After the 
incubation period, 400 µl of annexin-binding buffer were added and samples were kept on ice until being 
analyzed by flow cytometry. In order to visualize and discriminate the distribution of live (double 
negatives), dead (PI positive and annexin V FITC-negative), necrotic (double positives) and apoptotic 
(annexin V-FITC positive and PI negative) cells in the dot-plot of flow cytometry data, both annexin V 
FITC and PI were separately incubated with a mixture of live cells and cells killed by heat, for 15 min at 
80ºC, in a live:dead cells proportion of 1:1. This type of staining is called single staining and is used to 
determine the limits between each condition in the dot-plots.  
Measurements were performed in a BD LSRFortessa Flow Cytometer (BD Biosciences, San Jose, 
CA, USA), using a blue (488 nm) laser to excite stained cells. Green fluorescence (annexin V-FITC) 
emission was detected with a 530/30 bandpass filter and red fluorescence (PI) emission was detected with 
a 695/40 bandpass filter. Fluorescence emissions were acquired in biexponential scale and data were 
collected for 10 000 events using BD FACSDiva v. 6.2 (BD Biosciences). All flow cytometry results 




1. Susceptibility of planktonic C. albicans cells to Amph B, FCZ and Psd1 
The activity of Amph B and FCZ against the three C. albicans strains selected was determined by 
measuring their susceptibility to the antifungal drugs. The minimal inhibitory concentration (MIC) was 
calculated from the susceptibility curves obtained (shown in Fig. SF 2, in the Appendix - Supplementary 
data section). As shown in Table 1, the MICs of Amph B and FCZ show differences depending on the 
strain studied. The clinical isolate displays lower MIC values when compared to WT and ∆gcs. Growth 
inhibitory concentration values reported for Psd1 are more than 20-fold higher for WT and ∆gcs strains 
than those obtained for the same strains with different antifungal drugs. 
 
Table 1. Amph B, FCZ and Psd1 growth inhibitory concentrations used on the different C. albicans strains. 
* Psd1 concentration values obtained from Luciano de Medeiros Doctoral Thesis, Instituto de Biofísica Carlos 
Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil (2009). n.d. - not determined. 
 
Due to sample restrictions, susceptibility curves of the selected strains to Psd1 were not determined 
and the value considered was 90.0 µg/ml for both WT and Δgcs strains (Figure SF 3, in the Appendix – 
Supplementary data), previously determined by Luciano de Medeiros (de Medeiros, 2009). This was the 
value that fully inhibited C. albicans WT growth and caused an inhibition of 70% of C. albicans Δgcs 
growth. Although the value of the MIC for Psd1 on the clinical isolate was not determined, the value 
considered for all experiments was the same as used for WT and Δgcs. 
As seen in Table 1, the three C. albicans strains were sensitive to the selected drugs, Amph B and 
FCZ. For the clinical isolate, differences on MIC values of these drugs were related with the antifungal 
drug tested, contrary to WT and ∆gcs isolates that showed equal resistance (MIC values) for the same 
antifungic tested. 
 
2. Amph B, FCZ and Psd1 cause morphological alterations in C. albicans 
AFM imaging on intermittent contact mode was used to evaluate the effects suffered by C. albicans 
planktonic cells after incubation with Amph B, FCZ or Psd1. Antifungic concentrations tested were equal 
and 10-fold higher than MIC values determined previously (Table 1). Figures 12 and 13 show AFM 
images of C. albicans clinical isolate cells, after 6 and 24 h incubation periods, respectively, without 
(control) and after incubation with Amph B, FCZ or Psd1. Effects of these treatments show 
morphological changes in C. albicans cells. As seen, untreated cells have a smooth surface, a regular 
 Clinical isolate WT Δgcs 
Amphotericin B 1.0 µg/ml 4.0 µg/ml 4.0 µg/ml 
Fluconazole 1.5 µg/ml 4.0 µg/ml 4.0 µg/ml 
Psd1 n.d. 90.0 µg/ml * 90.0 µg/ml * 
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shape and cells gather in groups of 5 or more units (Figures 12 and 13, control). Regarding amphotericin 
B effects on clinical isolate, cells lose volume and membranes appear rougher. These effects increase in 
severity in a time-dependent manner, as seen in Figures 12 and 13, A-B. After a 24 h incubation with 
Amph B, cells are more wrinkled than after a 6 h incubation. After 6 h it is possible to observe small 
irregularities in the membrane (blebs) at an antifungic concentration 10-fold higher than the MIC (Figure 
12 B). It is also possible to observe that there are small vesicles deposited over and around the cells, on 
the glass slide, giving the appearance that the blebs are being released from the cells. Of the three 
treatments, Amph B is the one that induces a more extensive cell deformation. 
 
 
Figure 12. AFM error signal images of clinical isolate cells after 6 h incubation with Amph B, FCZ or Psd1. 




The clinical isolate seems to be less affected by FCZ, at both times of incubation and concentration 
of drug used (Figures 12 and 13, C-D), only with some irregularities in the cells membranes appearing 
after 24 h of incubation (Figure 13 C-D).  
Unlike Amph B and FCZ, Psd1 effects appear to be more severe. After 6 h of incubation (Figure 12 
E-F) and at both concentrations, the cells exhibit blebs in the membrane and, as it can be observed in 
Figure 12 F, one cell is completely covered of multiple blebs; probably the internal cell content is 
released along with the blebs that surround the cells. The height of the blebs, which is around 10 nm, is 
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shown in detail in Figure 14 and the pseudo-3D representation reveals that the blebs accumulate over 
each other, forming a bulk structure on top of the cell. After 24 h of incubation (Figure 13 E-F), however, 
unlike the 6 h incubation blebbing effect, the cells exhibit a peel-off-like morphology, as if small pieces 
of the membrane were breaking in between them and being removed from the surface of the cells. This 
effect is strongly prominent when the concentration of peptide is equal to the MIC (Figure 13 E).  
 
 
Figure 13. AFM error signal images of clinical isolate cells after 24 h incubation with Amph B, FCZ or Psd1. 




The height and pseudo-3D representation of the peels when Psd1 concentration is equal to the MIC 
are shown in Figure 15. When Psd1 concentration is equal to the MIC, the peels height is around 50 nm 
and, when Psd1 concentration is 10-fold higher, the peels height is around 171 nm (Figure 16). Of the 
three treatments, Psd1 is the one that has a stronger effect on reducing cells adhesion to each other, which 
may be the reason why it was difficult to find larger groups of cells gathered on the glass slide, as it was 
found for the control group and for Amph B and FCZ. 
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Figure 14. Blebbing detail on clinical isolate cell, after 6 h incubation with Psd1 (10 x MIC). The green square 
in the error signal image A (10 µm
2
) represents a selected new scan area of 1 µm
2
. Error signal (B) and height 
images (D) of the 1 µm
2
 selected area were used to make the pseudo-3D representation of the membrane blebs (C). 
The black line on image D is a cross-section over the blebs on the membrane. The cross-section is represented by 
the height profile E, which was used to determine the height of the blebs. The difference in height between 1 (cell 
membrane) and 2 (first bleb in the cross section) is 9.97 nm, while the difference between 1 and 3 (higher point in 
the bulk of the blebs) is 31.5 nm. 
 
 
Figure 15. Peeling detail on clinical isolate cell, after 24 h incubation with Psd1 (MIC).  
The green square in the error signal image A (10 µm
2
) represents a selected new scan area of 1 µm
2
. Error signal (B) 
and height images (D) of the 1 µm
2
 selected area were used to make the pseudo-3D representation of the membrane 
peels (C). The black line on image D is a cross-section over the peels on the membrane. The cross-section is 
represented by the height profile E, which was used to determine the height of the peels. The difference in height 
between 1 (base of the peel) and 2 (first peel in the section) is 48.4 nm. 
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Figure 16. Peeling detail on clinical isolate cell, after 24 h incubation with Psd1 (10 x MIC). Error signal (A) 
and height images (C) are 10 μm
2
 and were used to make a pseudo-3D representation of the membrane blebs (B). A 
cross-section on image C (black line), corresponding to the height profile D, was traced to determine the height of 
the peels: the difference in height between 1 (cell membrane) and 2 (peel) is 171 nm. 
 
There are some differences between clinical isolate and WT cells without antifungal treatment. WT 
cells do not have a regular shape or smooth surface (Figures 17 and 18, control) as clinical isolate cells 
(Figures 12 and 13, control) and they gather in smaller groups. 
After a 6 h incubating with Amph B, there is the appearance of blebs when the drug concentration 
is equal to the MIC value (Figure 17 A) and the membrane seems to be rougher than the control when the 
drug reaches a concentration 10-fold higher than the MIC (Figure 17 B). After 24 h of incubation, blebs 
were not visualized but cells seem to have released an amorphous mass of particles (Figure 18 A-B). For 









Similarly to the clinical isolate, FCZ is the treatment that had less effect on changing cells 
morphology for the WT strain. Blebs were not visible in any of the four conditions studied (Figures 17 
and 18, C-D), but there is an increase in membrane roughness (evident in Figure 17 C) and loss of cell 
volume after 6 h of incubation (Figure 17 D). Psd1 causes the appearance of blebs in the membrane of the 
cells for all conditions tested, as well as increased membrane roughness and cells covered by a bulk mass 
of debris (Figures 17, 18 E-F, and SF 4 in the Appendix - Supplementary data section) that also covers 










Figure 19. Volume loss suffered by WT cells after 24 h incubation with Psd1 (10 x MIC). A cross-section on 
image A (black line) was used to determine the height of the cells. The difference of height between the points 1 
(glass slide) and 2 (collapsed cell) is 203 nm and the difference between the points 1 and 3 (higher cell) is 1.88 µm. 




Compared to clinical isolate and WT cells, untreated mutant cells (control) have an apparent 
increase in membrane roughness regardless of the incubation time. These cells do not gather in groups 
and are mostly isolated cells with or without smaller cells budding from the mother cell, in pairs or in 
groups of three cells, although the latter is less frequent (Figures 20 and 21, control). This observation is 
the same for any of the treatments for this cell strain. 
Amph B effects in mutant cells are more related to the appearance of irregular topography on the 
cells surface (Figures 20 B and 21 A), although it is also possible to observe the deposit of small debris 
around the cells, especially when the drug reaches concentrations 10-fold higher than the MIC value 
(Figures 20 and 21 B). FCZ causes a decrease in cell volume after 6 h of incubation (Figure 20 C-D). 
When the drug is 10-fold higher than the MIC value, there is also the appearance of blebs in the 
membrane (Figure 20 D). 
After 24 h of incubation with the drug, the most radical effect is when FCZ is 10-fold higher than 
the MIC value, where it is possible to observe complete cell destruction (Figure 21 D). Psd1 has effects 
already observed for the other two strains, with blebbing of the membrane (Figures 20 F, 21 E-F and SF 5, 
in the Appendix - Supplementary data section) and release of vesicles to the surrounding areas when Psd1 
reaches the higher concentration (Figures 20 and 21 F). 
 
 











3. C. albicans suffers an increase in surface roughness after treatment with Amph B, 
FCZ or Psd1 
There is an overall increase of roughness on all the treatments performed, for all strains. These 
results (Figure 22), obtained with the RMS formula applied to 1 μm
2
 images of the surface of the 
membrane (Figure SF 6, in the Appendix - Supplementary data section), corroborating all the previous 
section's observations that membrane roughness increases after cells are submitted to any of the 
treatments. Regarding the control condition, clinical isolate and WT cells have lower surface roughness 
values, below 5 nm, whereas ∆gcs cells have higher surface roughness values, above 5 nm, being the 
roughest of the three strains. This relation between the three types of cells has also been concluded from 
the observation of AFM error signal images, in the previous section. WT cells were the most affected and 




Figure 22. Average surface roughness of C. albicans cells after treatment with Amph B, FCZ or Psd1. Two-
way ANOVA and Bonferroni post-tests were performed (*p < 0.05, **p < 0.01, ***p < 0.001). Error bars indicate 
the SEM. 
 
All treatments with Amph B cause a statistically significant increase of membrane roughness on 
clinical isolate and WT cells. This is not always the case for mutant cells, which although suffering an 
increase in membrane roughness after 6 h of incubation with a concentration equal to the MIC and 24 h 
incubation with a concentration 10-fold higher than the MIC (Figure 22 G), this increase in roughness is 
not statistically significant. When comparing the three cells treated with FCZ, fewer effects on membrane 
roughness were observed for clinical isolate and mutant cells (Figure 22 B and H). Contrary to this, WT 
cells were strongly affected by this treatment (Figure 22 E) and all conditions tested resulted in a 
statistically significant increase in membrane roughness. Psd1 increases clinical isolate's cells roughness 
in a similar way as Amph B does (Figure 22 A and C), whereas for WT cells the effects of Psd1 are 
similar in magnitude to those of FCZ (Figure 22 E and F). Again, as it was observed for Amph B and 
FCZ, mutant cells are the least affected by Psd1 but the defensin manages to strongly increase membrane 
roughness in these cells after 24 hours of incubation, with a peptide concentration 10-fold higher than the 
MIC (Figure 22 I). 
 
4. C. albicans loses stiffness after treatment with Amph B, FCZ or Psd1 
Changes in the stiffness of the cells were assessed in two different ways. One way is based on the 
determination of the Young's modulus of the membrane, using AFM-based force spectroscopy (for the 
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three treatments); and the other is based in the observation of AFM phase-contrast images of the cells 
surface, which allow to visualize and distinguish softer and stiffer areas in the membrane (for Psd1 only). 
 
4.1. Young's Modulus determination 
These experiments were performed after 24 h of incubation with an Amph B, FCZ or Psd1 
concentration 10-fold higher than the MIC. The clinical isolate has a mean value of membrane stiffness of 
354 ± 14 kPa (± standard error), WT has a mean value of 384 ± 14 kPa, and ∆gcs has a mean value of 315 
± 21 kPa. When ∆gcs cells mean value of stiffness is compared to the same value for WT cell, there is a 
reduction of 18% (red asterisk in Figure 23; *p < 0.05).  
 
 
Figure 23. Average stiffness of C. albicans cells after treatment with Amph B, FCZ or Psd1. Two-way 
ANOVA and Bonferroni post-tests were performed (*p < 0.05, **p < 0.01, ***p < 0.001). Error bars indicate the 
SEM. Values below the graphics, in dark red, are the percentage of reduction in stiffness, relative to the control 
condition. 
 
The percentage of stiffness reduction was calculated to better understand the different impacts of 
each treatment (values in the dark red box on the bottom of Figure 23). Amph B effects on cell stiffness 
were more severe for the mutant cells, with a reduction of 60% of the cell's initial stiffness. WT cells 
were the less affected by this treatment, with a 23% reduction of the initial stiffness. FCZ was the 
treatment with less effect on the three strains and its highest reduction on stiffness was registered on the 
WT cells, to which FCZ caused a reduction to nearly half of the initial stiffness. Psd1, of the three 
treatments, was the one that caused the highest reduction on stiffness of the clinical isolate, 67%, and WT 
cells, 57%, whereas for the mutant this was the treatment with a lower effect (34% stiffness reduction). In 
all cases, the treatment with the antifungal drugs, including Psd1, lead to statistically significant decreases 






4.2. Phase contrast imaging of C. albicans cells after Psd1 treatment 
With this type of AFM images, it is possible to visualize areas in a surface that have different 
softness (Magonov et al., 1997; Martinez and Garcia, 2006; Garcia et al., 2007; Nie et al., 2011). Phase 
contrast images of control cells of the three strains all present a homogenous surface. For the three strains, 
the results observed are roughly the same. Blebs in the membrane caused by the treatment with the 
peptide are softer than the surrounding membrane (Figures 24, 25 and 26, Phase contrast images) and 
even when there are no blebs formed, these images allow to distinguish softer and stiffer areas.  
 
Figure 24. Phase contrast and error signal images of clinical isolate cells after incubation with Psd1. Bars in 
the lower left corners represent 500 nm. 
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Figure 25. Phase contrast and error signal images of WT cells after incubation with Psd1. Bars in the lower left 





Figure 26. Phase contrast and error signal images of ∆gcs cells after incubation with Psd1. Bars in the lower 




5. Amph B, FCZ and Psd1 trigger apoptosis in C. albicans 
For flow cytometry experiments, WT and ∆gcs cells were incubated with a concentration of Amph 
B, FCZ or Psd1 equal to the MIC, for 24 h. According to the quadrants established (live, dead, necrotic 
and apoptotic cells), the percentages of apoptotic cells among the WT and ∆gcs control samples were 
determined to be 2.4% and 4.8%, respectively (Figures 27 and 28 C). 
Considering the WT cells, Amph B is the treatment with lower effects both in terms of killing cells 
and apoptosis triggering, having a distribution of cells in the dot plot similar to that of the control (Figure 
27 D). FCZ and Psd1 have similar effects in increasing apoptotic cells (Figure 27 E and F), but Psd1 
treated cells have a higher percentage of dead cells among them. 
 
 
Figure 27. Flow cytometry dot plots of WT cells after treatment with Amph B, FCZ or Psd1. Mix of live and 
dead cells (1:1) stained with annexin V-FITC (A) or propidium iodide (B); control cells stained with both dyes (C); 




∆gcs cells treated with Amph B or FCZ (Figure 28 D and E) show an increase in cells with a 
positive signal for the apoptotic marker, both for the cells still alive (i.e., in the quadrant of apoptotic cells) 
and dead (i.e., in the quadrant of necrotic cells). Psd1 also causes an increase in apoptotic and necrotic 
cells (Figure 28 F), but the strongest effect of the peptide is to increase the percentage of dead cells with 
negative signal for the apoptotic marker, from 11.7% (control) to 36.6%. 
 
 
Figure 28. Flow cytometry dot plots of ∆gcs cells after treatment with Amph B, FCZ or Psd1. Mix of live and 
dead cells (1:1) stained with annexin V-FITC (A) or propidium iodide (B); control cells stained with both dyes (C); 





The aim of using a strain of C. albicans with a mutation in the GlcCer synthase gene, as well as its 
wild type counterpart, was to evaluate the role of glucosylceramide in Psd1 antifungal effects against C. 
albicans. As determined previously, this defensin has a weaker effect in inhibiting the growth of C. 
albicans ∆gcs compared to the WT strain (de Medeiros, 2009), which after an incubation with 20µM of 
Psd1 was 70% and 100%, respectively, for each of the strains. In fact, some of the effects reported in this 
work are compatible with these evidences that Psd1 effects rely on the presence of this glycosphingolipid 
in the membrane of C. albicans. AMPs have been tested for their ability to affect physical properties of 
cells, such as morphology, size, height, roundness, and stiffness (Canetta et al., 2006; Tyagi and Malik, 
2010; Kim et al., 2011; Eaton et al., 2012). 
As seen in the section 2 of the Results - Amph B, FCZ and Psd1 cause morphological alterations in 
C. albicans, Psd1 considerably changes the morphology of the three strains used, and these effects can be 
seen on the lower concentrations, as well as with less time of incubation (i.e., after 6 h of incubation at the 
MIC). We can see the appearance of blebs in the membrane, the cell surface displays a peeling effect, 
volume loss, rougher aspect and a lower ability of cells to adhere to each other. The effects induced by 
Amph B and flucytosine, an azole, were previously imaged by SEM and AFM (Kim et al., 2011), and 
results similar to those obtained here, for Amph B and FCZ, were observed. Those authors also described 
a peeling like effect on C. albicans cells similar to the visualized here for Psd1. 
Considering the most commonly accepted models of AMP mechanisms of action referred in the 
Introduction - Models of membrane activity – mechanism of action of AMPs, the carpet model is the one 
that causes a larger decrease in membrane homogeneity  and, due to a detergent-like micellization, causes 
a great loss in membrane resistance (Chang et al., 2008). This model (carpet accumulation of peptide in 
the membrane's surface followed by a disorganization and micellization of the membrane) seems to be the 
most suitable to explain the blebs appearance and the rougher appearance of the membrane. A weakened 
membrane could suffer disruption, leading to the leakage of cellular contents, explaining the volume loss 
observed on some cells. By observing the error signal images, it is also possible to notice that Psd1-
treated cells do not aggregate like the control cells, or even like Amph B or FCZ-treated cells. This may 
be a sign that the defensin has some effect on changing cell's adhesion. This outcome may be explained 
by the disorganization introduced in the membrane by Psd1 and by its detergent-like action upon the 
membrane. The ability of planktonic cells to adhere to an abiotic surface and to other cells is an important 
virulence factor, and it is especially important to the formation of biofilms. By hindering this ability, Psd1 
testing against C. albicans biofilms becomes highly relevant.  
In the third section of the Results - C. albicans suffers an increase in surface roughness after 
treatment with Amph B, FCZ or Psd1, through surface analysis of AFM height (method used by 
Franquelim et al., 2013), it was possible to quantify the increase in membrane roughness that had been 
noticed by observing error signal images. All treatments, in a more or less statistically significant manner, 
increase cells surface roughness and the fact that the mutant cells are the less affected may be due to the 
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fact that these cells were already rougher than the clinical isolate and WT cells before treatment with 
Amph B, FCZ or Psd1. 
Regarding the Young's Modulus determination in the fourth section of Results - C. albicans loses 
stiffness after treatment with Amph B, FCZ or Psd1, some conclusions may be drawn relatively to the 
absence of GCS in the mutant's membrane. ∆gcs cells have a reduction of 18% in the average cell 
stiffness, comparing to its WT counterpart and this is expectably due to the lack of glucosylceramides in 
the membrane. Ceramides are proven to increase membranes rigidity, stability and structural organization 
of biological membranes (Sullan et al., 2009). When compared to Amph B or FCZ effects in membrane 
stiffness reduction, Psd1 has a stronger effect both on the clinical isolate and on the WT cells, with 
decreases of 67% and 57% relative to the control sample, respectively. The fact that Psd1 causes a 
substantially lower decrease on the stiffness of the mutant cells (34%) is strong evidence that this 
defensin has glucosylceramide as a molecular target in C. albicans membranes. Amph B strong reduction 
of mutant cells’ stiffness (60%) may be due to a synergistic effect between the pores formed by this 
antifungal drug and the lack of glucosylceramide in the membrane. As the binding of Amph B to 
ergosterol is irreversible, there is no way for the cell to repair the damage caused and the membrane is 
rendered with high instability and low resistance. 
By observing AFM phase contrast images of C. albicans after treatment with Psd1, it is possible to 
observe softer spots in the membrane, which coincide with the localization of blebs seen in error signal 
images. These softer areas are probably where the peptide accumulates and interacts with the membrane 
in a detergent-like manner, causing a disorganization and micellization of the lipids of the membrane and, 
consequently, a weakened membrane.  
Psd1 is a trigger of apoptosis in both C. albicans strains tested by flow cytometry. The peptide has 
a stronger effect than Amph B or FCZ. The comparison of the results obtained for both strains tested are 
not coincident with the fact that the mutant lacks glucosylceramide in the membrane, indicating that this 
effect of the peptide does not depend on the existence of GlcCer in the membrane. Probably due to the 
cell being more fragile without glucosylceramide, the addition of an antifungal peptide would increase 
cell's susceptibility, hence increasing the percentage of cells undergoing apoptosis. Also, the fact that the 
flow cytometry dot-plot of C. albicans WT only registers 13% of dead cells, when the Psd1 concentration 
used is equal to the MIC, points out to a non-disruptive mechanism of action of Psd1 (Lobo et al., 2007). 
This is equally valid for C. albicans ∆gcs, which registers 41% of dead cells at the same Psd1 
concentration. Given that the condition "Dead" in this flow cytometry experiment is defined by the 
positive signal of the fluorescent stain propidium iodide and that this stain is permeant to cells with 
corrupted membranes, the previous observation, based on flow cytometry data, indicates that this defensin 
antifungal action may not be through a membrane disrupting mechanism. Some mechanisms of action of 
antifungal peptides have been reported, such as binding to the cell wall, induction of signaling cascades 
and interaction with intracellular targets, which would lead to apoptosis, membrane permeabilization and 
receptor-mediated internalization (Thevissen et al., 2003; Thevissen et al., 2004; van der Weerden et al., 
2013). As previously reported, Psd1 interacts with a N. crassa cell cycle protein cyclin F and halts the cell 
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cycle (Lobo et al., 2007). Due to this, it is possible that Psd1, besides its negative effects observed on the 
membrane, may also enter into C. albicans cells and interact with an intracellular target, causing 
apoptosis. 
 
Conclusions and future perspective 
This work elucidates some aspects of the Pisum sativum defensin 1 antifungal activity that had not 
been investigated so far. It was possible to conclude that the most likely model to explain the mechanism 
of interaction of the peptide with Candida albicans is the carpet model with micellization of the 
membrane and a detergent-like effect on the membrane surface, which supports the appearance of 
features in the membrane, such as blebs and an increased membrane roughness. This defensin is likely to 
interact with glucosylceramide present in C. albicans cell membrane, causing a decrease in membrane 
stiffness. Psd1 is also a triggering agent of apoptosis in this human pathogen. 
By hindering cells ability to adhere, Psd1 may also contribute to preventing an infection to 
proliferate by reducing the adherence of new C. albicans to the infected tissue. It is also possible to 
consider that Psd1 may interfere with biofilm formation, which depends highly on cell-substrate and cell-
cell adherence, as well as on quorum sensing (Inigo et al., 2012). In fact, a research line with this focus 
has already been set in motion. Psd1 is being tested against C. albicans biofilms to evaluate its ability to 
eradicate a biofilm, and the peptide is also being tested for its ability to prevent biofilm formation upon 
being added to the cells before the biofilm is formed. 
The knowledge on antimicrobial peptides has been increasing considerably during the last 20 years. 
This increased knowledge lead to the notion that AMPs have much more than just strict antimicrobial 
activity, presenting a broad spectrum of physiological functions. In general, AMPs may have limitations 
in terms of new drug development, due to their cationic, amphiphilic and protease labile nature, leading to 
a low serum half-life that limits their systemic administration (Maisetta et al., 2008). This limitation can 
be overcome by the use of peptidomimetics, like the substitution of natural occurring L-amino acids by 
D-amino acids or unusual ones (Oren et al., 1997; McPhee et al., 2005). Defensins bare a favorable 
characteristic against this problem, as their disulphide-stabilized structure confers an increased protease-
resistance (Wu et al., 2003). Apart from the need to check their citotoxicity to human cells, the fact that 
some AMPs (e.g., LL-37) have the ability to translocate into cells and inside the nucleus (Sandgren et al., 
2004) needs to be taken into account as well. 
Nonetheless, AMPs may combine targeted antimicrobial activity with the capacity to positively 
modulate the immune system and have proven to be effective across Life evolution, making these 
peptides highly appealing as an anti-infective strategy. The molecular design and synthesis of new 
molecules inspired on AMPs structure and sequence seem to be a promising approach to open a new and 
extensive field of applications, ranging from antimicrobial therapy, to their possible use as vaccine 
adjuvants. Therefore, a better understanding of function and mechanism of action of host defense peptides 
is a great promise in anti-infective and immunomodulatory therapeutics.  
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This section includes information and results that complement the text of the previous chapters. 
The reader will find some of the outcomes of this work in terms of publications and communications, 
which include two abstract of posters presented in congress and the abstract of a review article focused in 
antifungal defensins. Also in this section is an original article that studies the effects of the AMP rBPI21 
against Escherichia coli and Staphylococcus aureus, that relies on some of the techniques employed in 
this thesis. Furthermore, the data presented in this thesis will also be converted in an additional 
manuscript, to be submitted to an international peer-reviewed journal during the upcoming months. 
 
Supplementary data 
Figure SF1. Force map of C. albicans WT cells after 24 h 
incubation with Amph B. 
These cells were treated with an Amph B concentration 10-fold 
higher than the MIC. Force maps like the one exemplified here 
were used to perform AFM-based force spectroscopy assays for 
the Young's Modulus determination. Each pixel (square) in the 
image has a coordinate and the highest pixel (the lighter the 
color, the higher the coordinate)  in each cell was chosen to 





Figure SF2. Susceptibility curves of Amph B or FCZ against the C. albicans clinical isolate, WT and ∆gcs cells. 
Curves were fitted and the MIC value was obtained using the Gompertz equation. 
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Figure SF3. Growth inhibition curve of C. albicans WT and ∆gcs by Psd1. Results represent four independent 




Figure SF4. Blebbing detail of C. albicans WT cell after 24 h incubation with Psd1 (10 x MIC). Error signal (A) 
and height images (C) are 1μm
2
 and were used to make a pseudo-3D representation of the membrane blebs (B). 
Cross-section of image C (black line), represented by the height profile D, was traced to determine the height of the 
blebs: the difference in height between 1 (cell membrane) and 2 (first bleb in the cross section) is 13.8 nm, while the 
difference between 1 and 3 (lower point in the bulk of blebs) is 12.8 nm. 
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Figure SF5. Blebbing detail of C. albicans ∆gcs cell, after 24 h incubation with Psd1 (10 x MIC). Error signal 
(A) and height images (C) are 2 μm
2
 and were used to make a pseudo-3D representation of the membrane blebs (B). 
A cross-section on image C (black line), represented by the height profile D, was used to determine the height of the 
blebs: the difference of height between 1 (cell membrane) and 2 (first bleb in the cross section) is 7.83 nm, while the 
difference between 1 and 3 (higher point in the bulk of blebs) is 36.5 nm. 
 
 
Figure SF6. Height images of C. albicans ∆gcs cells after 6 h treatment with Psd1 (10 x MIC). The red square 
in A is 1 µm
2
 and B is the cropped area of the red square after leveling. Several crops like this over one cell were 




Outcomes of the present thesis 
The following first two abstracts are relative to the posters presented by me and Sónia Gonçalves, 
respectively, at the 9
th
 European Biophysics Congress – EBSA 2013, published in the European Biophysical Journal. 
    
Antifungal defensin Psd1 increases membrane roughness and promotes apoptosis in 
Candida albicans 
Patrícia M. Silva a, Sónia Gonçalves a, Luciano Neves de Medeiros b, Eleonora Kurtenbach b, 
Nuno C. Santos a 
a Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal 
b Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil 
Psd1 is a defensin, isolated from Pisum sativum seeds, previously shown to have a strong interaction with 
fungal-specific membrane components [1]. Candida albicans is an important human pathogen, causing oral, genital 
and systemic opportunistic infections, which are especially relevant clinically in immunocompromised patients, such 
as HIV-infected individuals. We tested the effects of this antimicrobial peptide, comparing it with the antifungal 
drugs amphotericine B and fluconazole, at the minimal inhibitory concentration (MIC) and at a 10-fold higher 
concentration. By atomic force microscopy (AFM) imaging we assessed morphological changes on C. albicans cells. 
SYTO-9 and propidium iodide allowed us to image live and dead cells by confocal microscopy and to quantify their 
ratio. Our results show that, with increasing incubation times and Psd1 concentrations, there is an increased cell 
death and surface roughness, with the appearance of apoptotic features, such as membrane blebs, cell size alterations, 
membrane disruption and leakage of cellular contents. Thus, we were able to visualize the action of Psd1 against a 
relevant fungal human pathogen, aiming at its possible use as a natural antimycotic agent. 
[1] Gonçalves et al. (2012) Biochim Biophys Acta 1818:1420 
      




, Patrícia M. Silva 
a
, Luciano Neves de Medeiros 
b
, Eleonora Kurtenbach 
b
, 
Nuno C. Santos 
a 
a Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal 
b Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil 
Biofilms represent the most common type of microbial growth in nature and are crucial to the development of 
clinical infections. Candidiasis associated with intravenous lines and bioprosthetic devices is problematic, since 
these devices can act as substrates for biofilm growth. In the present work Candida albicans biofilm formation was 
studied in the absence and in presence of a defensin, Psd1 [1], and two current antimicotic drugs: amphotericine B 
and fluconazole. Three C. albicans variants were studied, one of them a mutant deficient in glucosylceramide 
synthase, conferring resistance to Psd1 antifungal action. Differences in the biofilm formation were encountered for 
the variants studied. Atomic force microscopy (AFM) images showed that during the biofilm growth a structured 
mesh of fungal cells is formed with 1.2-1.5 M height (single cell have 500-600 nm). The action of the three 
antifungal agents was evaluated both in terms of inhibition of the biofilm formation and disruption of previously 
formed biofilm. 
[1] Gonçalves et al. (2012) Biochim Biophys Acta 1818:1420 
   
Next are the abstracts of the two manuscripts I am co-author of. The third abstract is of a review with a 
subject closely related to this thesis work, which is submitted for publication in the journal Frontiers in 
Antimicrobials, Resistance and Chemotherapy. The manuscript is under editorial revision and was considered as 
acceptable with minor changes. 
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Defensins: antifungal lessons from eukaryotes 
Patrícia M. Silva, Sónia Gonçalves, Nuno C. Santos 
Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal 
Pathogenic fungi resistance to conventional antimycotic drugs is becoming a major problem as fungal 
infections in immunocompromised patients, as well as infections caused by primary pathogenic fungi, are leading to 
clinical situations hard to overcome. Furthermore, in agriculture, phytopathogenic fungi lower crop yields and 
increase food stock price, resulting in an enormous economic burden. Over the last years, antimicrobial peptides 
(AMPs) have been the focus of intense research towards finding a viable alternative to current antifungal drugs. 
Defensins are cysteine-stabilized AMPs found in plants, animals and fungi, which provide an important first line of 
host defense against microorganisms, demonstrating a relevant effect against pathogenic fungi. The fact that 
defensins act as an important vehicle of information between innate and adaptive immune system and that there are 
structural homologies between defensins from diverse eukaryotic origins demonstrate the difficulty of 
microorganisms in facing this host shield. Defensins, as other AMPs, may become the basis for effective 
antimycotic therapies. 
Keywords: antimicrobial peptides; defensins; antifungal; resistance; host defense peptides. 
    
The fourth abstract, although of a manuscript not related to this thesis, employs some of the same techniques 
to study another AMP. It was submitted for publication in the journal Nanomedicine (NBM) and is under editorial 
revision after the submission of a revised version. It was also considered acceptable with minor changes. 
 
Antimicrobial protein rBPI21-induced surface changes on Gram-negative and 
Gram-positive bacteria 
Marco M. Domingues, Patrícia M. Silva, Henri G. Franquelim, Filomena A. Carvalho, Miguel A.R.B. 
Castanho, Nuno C. Santos 
Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisbon, 
Portugal. 
New classes of antibiotics, such as antimicrobial peptides or proteins (AMPs), with new modes of action, are 
crucial to deal with threatening bacterial diseases. rBPI21 is an AMP based on the human neutrophil BPI protein, 
with potential clinical use for meningitis. We studied the membrane perturbations promoted by rBPI21 on Gram-
negative Escherichia coli and Gram-positive Staphyloccoccus aureus. Its interaction with bacteria was also studied 
in the presence of lipopolysaccharide (LPS), rBPI21 major ligand. Flow cytometry analysis of both E. coli and S. 
aureus shows that rBPI21 induces membrane depolarization. rBPI21 increases the negative surface charge of both 
bacteria toward positive values, as shown by zeta-potential measurements. This charge modification is followed by 
surface perturbations, culminating in cell lysis, as visualized by atomic force microscopy (AFM). Force 
spectroscopy measurements show that soluble LPS decreases the interaction of rBPI21 with bacteria, being this effect 
more pronounced for S. aureus. This indicates that rBPI21 is able to interact with Gram-positive bacteria using the 
same domain involved on LPS-binding. 
Keywords: Lipopolysaccharide; rBPI21; atomic force microscopy.
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